GlassScriptPhysician profile
Jesse M Markowitz
NPI 1639559479
$1,509.84
in general payments reported to CMS, 2019-2025
25 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $457 · 2023: $244 · 2024: $277 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $227.15 | 2021-2024 | Orthovisc, Monovisc |
| Vertos Medical, INC. | $131.00 | 2021 | |
| Ferring Pharmaceuticals INC. | $125.58 | 2022-2025 | Euflexxa |
| Amgen INC. | $123.51 | 2022-2025 | Evenity, Prolia, Krystexxa |
| Stryker Corporation | $119.16 | 2024 | Mako, Omnicurve |
| Smith+Nephew, INC. | $81.52 | 2022 | |
| Radius Health, INC. | $70.77 | 2021-2025 | Tymlos |
| Sanofi-Aventis U.S. LLC | $59.88 | 2022-2023 | |
| Kowa Pharmaceuticals America, INC. | $55.68 | 2022-2023 | Seglentis |
| Alexion Pharmaceuticals, INC. | $54.98 | 2022-2023 | Strensiq |
| Providence Medical Technology, INC. | $53.04 | 2024 | |
| Zimmer Biomet Holdings, INC. | $52.95 | 2025 | Totalshield |
| Horizon Therapeutics Plc | $37.65 | 2022 | |
| Fidia Pharma USA INC. | $36.81 | 2023-2025 | Hymovis |
| Vertex Pharmaceuticals Incorporated | $32.63 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alvogen INC | $31.51 | 2023 | Teriparatide |
| Ucb, INC. | $28.93 | 2021 | |
| Treace Medical Concepts, INC. | $27.23 | 2025 | |
| Electronic Waveform Lab, INC. | $26.86 | 2025 | |
| Medtronic, INC. | $25.97 | 2025 | Inceptiv |
| Orthofix Medical, INC. | $25.18 | 2024 | Physio-Stim |
| Bioventus LLC | $24.56 | 2025 | Xcell |
| Seapearl East, INC | $21.06 | 2025 | |
| Heron Therapeutics, INC. | $19.64 | 2022 | |
| Molnlycke Health Care US, LLC | $16.59 | 2023 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Markowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.